Kontafarma China files board, committee and disclosure management list

• Kontafarma China set a new board lineup effective Aug. 17, 2026, naming Wang Limin chairman, Li Qingshan president.
• Executive directors include Ge Shouwen as vice president, Guo Zixiu as financial controller.
• Independent non-executive directors: Tang Lai Wah, Ho Ho Ming, Yao Xiaomin.
• Wang chairs the Executive Committee, Nomination Committee, Share Dealing Committee, Investment Committee.
• Tang chairs Audit; Ho chairs Risk Management; Yao chairs Remuneration, with committee roles spread across the independent directors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12287619), on August 17, 2026, and is solely responsible for the information contained therein.